In this introduction to MDMA-Assisted Therapy, Dr. Darek Dawda discusses a few key concepts necessary for the understanding of this novel therapy.

In this 3-episode podcast series, we present numerous personal accounts of experiences with MDMA, both in the recreational and therapeutic context. These interviews were recorded at the historic Psychedelic Science 2023 conference in Denver, the largest gathering to date of people who work on advancing the research, access, and legalization of psychedelic-assisted therapies.

In this 3-episode podcast series, we present numerous personal accounts of experiences with MDMA, both in the recreational and therapeutic context. These interviews were recorded at the historic Psychedelic Science 2023 conference in Denver, the largest gathering to date of people who work on advancing the research, access, and legalization of psychedelic-assisted therapies.

In this 3-episode podcast series, we present numerous personal accounts of experiences with MDMA, both in the recreational and therapeutic context. These interviews were recorded at the historic Psychedelic Science 2023 conference in Denver, the largest gathering to date of people who work on advancing the research, access, and legalization of psychedelic-assisted therapies.

Working within the Harm Reduction approach, Mark Haden (Director of Research @ PsyGen, Professor of Public Health @ UBC, and Former Executive Director of MAPS Canada) discusses his book "Manual for Psychedelic Guides." Mark's insights are also applicable to MDMA-Assisted Therapy and other Psychedelic-Assisted Therapies.

Scott Bernstein, a drug policy and human rights lawyer, discusses the January 5, 2022 news-making amendment to Canadian drug laws that has direct implications for access to MDMA Assisted Therapy. Is this big news or not? What does the amendment mean? Who might be eligible for MDMA-Assisted Therapy? Is Canada leading the world? And what is the next step in the process of making MDMA-Assisted Therapy available to Canadians in need?

The Multidisciplinary Association for Psychedelic Studies (MAPS) has just launched the world’s first and much anticipated MDMA-Assisted Therapy Training Program.

New York psychologist Ingmar Gorman, one of the principal investigators on FDA approval research for MDMA-Assisted Therapy, discusses recent results from a pivotal study that some argue might revolutionize the future of mental health and well being.

An MDMA Therapy pioneer, a UK psychiatrist Ben Sessa, discusses groundbreaking novel research on MDMA Therapy for Alcohol Abuse.

In this episode, Lori describes how MDMA-Assisted Therapy helped her heal trauma. Lori is awash in gratitude and clarity of rare proportions. This is a powerful personal testimony that is bound to open your heart.

Gül describes recent ground-breaking neuroscientific discoveries that explain how MDMA-Assisted Therapy might heal relationships.

Berlin's MIND Foundation is one of Europe's largest psychedelic therapy organizations with global aspirations. MIND has a range of amazing programs for therapists, academics, and anyone else interested in new psychedelic therapies.

That's right, we started a new podcast focussed on MDMA-Assisted Therapy, and in a broader sense on other Psychedelic-Assisted Therapies. The goal of this podcast is to connect you with world's leading experts, provide you with high quality educational information, and hopefully have some fun.